drugset / Trial / NCT04858620
A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection
RandomizedCrossoverSingle-blindTreatment
Summary
This study aims to find out the efficacy of Xlear nasal spray as an adjunct medication against COVID-19. This encompasses reduction in the number of days to negativization via nasal swab PCR from the average 14 days and early improvement of symptoms.
Timeline
- Start
- 2020-08-30
- Primary completion
- 2021-08-30
- Completion
- 2021-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Grapefruit Seed Extract | Unknown | — | Intranasal |
| Subject | Xylitol | Small molecule | — | Intranasal |